共 138 条
[1]
Tester DJ(2017)Evaluating the survivor or the relatives of those who do not survive: the role of genetic testing Cardiol Young 27 S19-S24
[2]
Ackerman MJ(2009)Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants Circulation 120 1752-1760
[3]
Kapa S(2018)Role of genetic heart disease in sentinel sudden cardiac arrest survivors across the age spectrum Int J Cardiol 270 214-220
[4]
Giudicessi JR(2018)Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience Hong Kong Med J 24 340-349
[5]
Ackerman MJ(2018)Next generation sequencing applications for cardiovascular disease Ann Med 50 91-109
[6]
Mak CM(2019)Sudden arrhythmia death syndrome in young victims: a five-year retrospective review and two-year prospective molecular autopsy study by next-generation sequencing and clinical evaluation of their first-degree relatives Hong Kong Med J 25 21-29
[7]
Kalayinia S(2010)A new approach to long QT syndrome mutation detection by Sequenom MassARRAY system Electrophoresis 31 1648-1655
[8]
Mak CM(2017)Considerations when using next-generation sequencing for genetic diagnosis of long-QT syndrome in the clinical testing laboratory Clin Chim Acta 464 128-135
[9]
Allegue C(2015)Genetic analysis of arrhythmogenic diseases in the era of NGS: the complexity of clinical decision-making in Brugada syndrome PLoS ONE 10 126-140
[10]
Chae H(2013)An update on channelopathies: from mechanisms to management Circulation 127 418-425